FAM90A19: A Potential Drug Target and Biomarker for Family with Sequence Similarity 90 Member A19

Target Name: FAM90A19

NCBI ID: G728753

FAM90A19

FAM90A19: A Potential Drug Target and Biomarker for Family with Sequence Similarity 90 Member A19

Sequence similarity 90 member A19 (FAM90A19) is a gene located on chromosome 6p21.1 that has been implicated in various health conditions, including cancer, neurodegenerative diseases, and autoimmune disorders. FAM90A19 is a pseudogene, which means that it does not encode a functional protein but instead functions as a genetic signature for the presence of certain genetic variations.

The discovery of FAM90A19 as a potential drug target and biomarker has significant implications for the development of new treatments for a variety of diseases. In this article, we will explore the biology of FAM90A19 and its potential as a drug target, as well as its potential as a biomarker for various diseases.

The Biology of FAM90A19

FAM90A19 is a pseudogene that is located on chromosome 6p21.1. It is a member of the FAM90 gene family, which is characterized by a conserved sequence that includes a hypervariable region (HVR) and a variable region (VHR). The HVR is responsible for the diversity of the FAM90 proteins, while the VHR is responsible for the specificity of each protein.

Studies have shown that FAM90A19 is highly conserved across various species, including humans, with a conservation score of 86.6% at the amino acid level and 94% at the nucleotide level. This conservation suggests that FAM90A19 may be a highly conserved gene that is involved in a wide range of biological processes.

FAM90A19 has also been shown to be involved in various signaling pathways, including the TGF-β pathway, the PI3K/Akt pathway, and the NF-kappa-B pathway. These pathways are involved in various cellular processes that are important for normal development, wound healing, and disease progression.

FAM90A19 as a Drug Target

FAM90A19 has been shown to be involved in various signaling pathways that are important for disease progression. For example, studies have shown that FAM90A19 is involved in the regulation of cell proliferation and has been shown to promote the growth of cancer cells.

FAM90A19 has also been shown to be involved in the regulation of cell apoptosis, which is the process by which cells die when they have reached a certain level of stress or damage. Studies have shown that FAM90A19 is involved in the regulation of cell apoptosis and has been shown to protect cancer cells from apoptosis.

FAM90A19 has also been shown to be involved in the regulation of tissue repair and regeneration. For example, studies have shown that FAM90A19 is involved in the regulation of tissue repair and regeneration after injury or disease.

FAM90A19 as a Biomarker

FAM90A19 has been shown to be involved in various signaling pathways that are important for disease progression. This suggests that FAM90A19 may be a useful biomarker for various diseases.

For example, studies have shown that FAM90A19 is involved in the regulation of cell proliferation and has been shown to promote the growth of cancer cells. This suggests that FAM90A19 may be a useful biomarker for cancer.

FAM90A19 has also been shown to be involved in the regulation of cell apoptosis and has been shown to protect cancer cells from apoptosis

Protein Name: Family With Sequence Similarity 90 Member A19

The "FAM90A19 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about FAM90A19 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets